Business Description
Portage Biotech Inc
NAICS : 325412
SIC : 2836
ISIN : VGG7185A1021
Description
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.42 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.01 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -141 | |||||
| 3-Year EPS without NRI Growth Rate | -21.5 | |||||
| 3-Year FCF Growth Rate | -30.2 | |||||
| 3-Year Book Growth Rate | -21.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 236.84 | |||||
| 12-1 Month Momentum % | 255.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | |||||
| Quick Ratio | 2.78 | |||||
| Cash Ratio | 1.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17 | |||||
| Shareholder Yield % | -12.77 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -173.34 | |||||
| ROA % | -131.82 | |||||
| ROIC % | -16.29 | |||||
| ROC (Joel Greenblatt) % | -47768.97 | |||||
| ROCE % | -157.72 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 0.05 | |||||
| PB Ratio | 0.15 | |||||
| EV-to-FCF | 0.01 | |||||
| Price-to-Projected-FCF | 60.44 | |||||
| FCF Yield % | -233.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Portage Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 27.02 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 255.56 | ||
| 52-Week Range ($) | 8.5 - 41.9 | ||
| Shares Outstanding (Mil) | 12.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Portage Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Portage Biotech Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Portage Biotech Inc Frequently Asked Questions
What is Portage Biotech Inc(XCNQ:PBT.U)'s stock price today?
The current price of XCNQ:PBT.U is $27.20. The 52 week high of XCNQ:PBT.U is $41.90 and 52 week low is $8.50.
When is next earnings date of Portage Biotech Inc(XCNQ:PBT.U)?
The next earnings date of Portage Biotech Inc(XCNQ:PBT.U) is 2024-05-15 Est..
Does Portage Biotech Inc(XCNQ:PBT.U) pay dividends? If so, how much?
Portage Biotech Inc(XCNQ:PBT.U) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers